ANTIFUNGAL RESISTANCE IN DERMATOMYCOSES: CURRENT TREATMENT CHALLENGES
CENTRAL ASIAN DERMOTOLOGY · 14.10.2026 · 17 (3) · 112
DOI: 10.67620/dermajournal.1730075 ↗Kurz gefasst
Fachartikel in der Zeitschrift CENTRAL ASIAN DERMOTOLOGY, online erschienen am 14.10.2026. Verfasst von М Maxmudjonov.
Abstract (Originalsprache)
Dermatomycoses affect an estimated 20–25% of the global population. Over the past five years, this burden has been compounded by the rapid emergence of Trichophyton indotineae, a terbinafine-resistant dermatophyte first identified on the Indian subcontinent and now documented across more than 40 countries (da Silva et al., 2026). Reported resistance rates for this pathogen vary considerably across the literature, ranging from 5% to over 77%, a discrepancy risking misinterpretation as inconsistent evidence rather than a predictable consequence of study design.
Zitieren
APA
Maxmudjonov, М. (2026). ANTIFUNGAL RESISTANCE IN DERMATOMYCOSES: CURRENT TREATMENT CHALLENGES. CENTRAL ASIAN DERMOTOLOGY, 17(3), 112. https://doi.org/10.67620/dermajournal.1730075
Vancouver
Maxmudjonov М. ANTIFUNGAL RESISTANCE IN DERMATOMYCOSES: CURRENT TREATMENT CHALLENGES. CENTRAL ASIAN DERMOTOLOGY. 2026;17(3):112. doi:10.67620/dermajournal.1730075
BibTeX
@article{Maxmudjonov2026,
author = {Maxmudjonov, М},
title = {ANTIFUNGAL RESISTANCE IN DERMATOMYCOSES: CURRENT TREATMENT CHALLENGES},
journal = {CENTRAL ASIAN DERMOTOLOGY},
year = {2026},
volume = {17},
number = {3},
pages = {112},
doi = {10.67620/dermajournal.1730075}
}
EUVIMED